32 Chapter 2 treatment. Further research is required to understand morbidity post-tuberculosis treatment and its association with HIV. References 1. World Health Organisation. Tuberculosis Fact Sheet Geneva: WHO; 2021 [cited 2022 25 May]. Available from: http://www.who.int/news-room/fact-sheets/detail/tuberculosis. 2. International Diabetes Federation. Diabetic facts and figures Brussels, Belgium: IDF; 2021 [updated 09/12/2021; cited 2022 23 May]. Available from: https://www.idf.org/aboutdiabetes/what-isdiabetes/facts-figures.html. 3. World Health Organisation. Diabetes Key Facts Geneva: WHO; 2021 [updated 10 November 2021; cited 2022 25 May]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes. 4. Faurholt‐Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt‐Jepsen M, Aabye MG, et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania. Tropical Medicine & International Health. 2013;18(7):822-9. https://doi.org/10.1111/tmi.12120 5. Jiménez-Corona ME, Cruz-Hervert LP, García-García L, Ferreyra-Reyes L, Delgado-Sánchez G, Bobadilla-del-Valle M, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013;68(3):214-20. https://doi.org/10.1136/ thoraxjnl-2012-201756 6. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC medicine. 2011;9(1):1-15. https://doi. org/10.1186/1741-7015-9-81 7. Root HF. The association of diabetes and tuberculosis. New England Journal of Medicine. 1934;210(3):127-47. 8. Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2· 3 million patients with tuberculosis. The Lancet Global Health. 2019;7(4):e448-e60. https://doi.org/10.1016/ S2214-109X(18)30487-X 9. Alebel A, Wondemagegn AT, Tesema C, Kibret GD, Wagnew F, Petrucka P, et al. Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies. BMC infectious diseases. 2019;19(1):1-10. https://doi. org/10.1186/s12879-019-3892-8 10. Magee MJ, Salindri AD, Kyaw NTT, Auld SC, Haw JS, Umpierrez GE. Stress hyperglycemia in patients with tuberculosis disease: epidemiology and clinical implications. Current diabetes reports. 2018;18(9):1-10. https://doi.org/10.1007/s11892-018-1036-y 11. Luies L, du Preez I. The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications. Clinical microbiology reviews. 2020;33(4). https:// doi.org/10.1128/CMR.00036-20 12. Cheng P, Wang L, Gong W. Cellular Immunity of Patients with Tuberculosis Combined with Diabetes. Journal of Immunology Research. 2022;2022. https://doi.org/10.1155/2022/6837745
RkJQdWJsaXNoZXIy MTk4NDMw